CYTOKINETICS INC — Director's Dealing 2021

Feb 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-02-18

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-18	Common Stock	M	10409	$9.42	Acquired	315998	Direct
2021-02-18	Common Stock	F	6652	$21.01	Disposed	309346	Direct
2021-02-18	Common Stock	M	72923	$9.42	Acquired	382269	Direct
2021-02-18	Common Stock	F	47896	$21.01	Disposed	334373	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-18	Incentive Stock Option (right to buy)	$9.42	C	10409	Disposed	2021-02-28	Common Stock (10409)	Direct
2021-02-18	Non-Qualified Stock Option (right to buy)	$9.42	C	10409	Acquired	2021-02-28	Common Stock (10409)	Direct
2021-02-18	Non-Qualified Stock Option (right to buy)	$9.42	M	10409	Disposed	2021-02-28	Common Stock (10409)	Direct
2021-02-18	Non-Qualified Stock Option (right to buy)	$9.42	M	72923	Disposed	2021-02-28	Common Stock (72923)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: Includes 4,991 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).

F2: Transaction represents a "net exercise" of 72,923 outstanding non-qualified stock options granted on 2/28/2011 and 10,409 outstanding non-qualified stock options that result from the conversion on 2/18/2021 of incentive stock options granted on 2/28/2011. The Reporting Person received 28,784 shares of Common Stock on the net exercise of a stock options to purchase an aggregate of 83,332 shares of Common Stock, with a remaining payable by Reporting Person to the Issuer of $18.24. The Issuer withheld 54,548 shares of Common Stock underlying the stock options for payment of the exercise price and tax withholding using a stock price on 2/18/2021 of $21.01. In addition to the withholding of 54,548 shares of Common Stock, the Reporting Person will pay $18.24 in cash to the Issuer for the remainder of his exercise price and tax liability.

F3: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F4: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F5: Incentive stock options granted on 2/28/2011 to purchase 10,409 shares at an exercise price of $9.42 per share converted to non-qualified stock options to purchase 10,409 shares at an exercise price of $9.42 per share as a result of a modification to the original grant to permit a "net exercise" of the stock options. Conversion transaction is permitted pursuant to the Issuer's Amended and Restated 2004 Equity Incentive Plan and the prior resolution of the Issuer's Compensation and Talent Committee of the Board of Directors.